Chronic wounds are a major complication for diabetes mellitus (DM) patients, which cause discomfort and an increase in medical costs. The purpose of this study is to investigate the medical application and possible mechanisms of a cold atmospheric plasma jet in healing DM chronic wounds. In this paper, the genetic diabetic BKS.DB mice are used as the diabetic wound healing animal model, which have a stable glucose level and can avoid the effects or complications induced by surgical and chemical interventions. The helium atmospheric-pressure dielectric-barrier-discharge (AP-DBD) plasma jet is employed to treat the diabetic mice wounds with the fixed treatment time and distance of 15 s and 20.0 mm, respectively. The wound healing, histological, immunohistochemical, and cytokine analyses are conducted to evaluate the efficacy of the helium AP-DBD plasma jet on the chronic wound healing of the genetic diabetic mice. The experimental results show that the helium AP-DBD plasma jet treatment of wounds of genetic diabetic mice can regulate the secretion of transforming growth factor- $\beta $ (TGF- $\beta$ ) and fibroblast growth factors (FGFs), limit the inflammatory response and excessive cell proliferation, accelerate the process of re-epithelialization, and consequently, promote the chronic wound healing process.
24 July 2018 in IEEE Transactions on Plasma Science
It is a useful method to lengthen the cold atmospheric plasma jet with the aid of gas shielding. In this paper, the interactions between the shielding gas and the radio-frequency atmospheric-pressure glow discharge plasma jet are studied numerically and experimentally. The modeling results show that both the chemical compositions and flowrates of the shielding gas strongly influence the characteristics of the plasma jets. A long helium-shielding plasma jet with a length of 34-35 mm is obtained. The predicted lengths of the plasma shielding jets under specified operating conditions are qualitatively consistent with the experimental measurements.
2 August 2021 in IEEE Transactions on Plasma Science
Surgical incision infection of multidrug-resistant microorganisms (e.g., methicillin-resistant Staphylococcus aureus , MRSA) is a severe cause of poor wound healing, which is prevalent in healthcare facilities and constitutes a huge infectious disease burden in the world. The purpose of this study is to investigate the medical application and possible mechanisms of the cold atmospheric plasma jet on infected wounds. In this article, the New Zealand rabbit in vivo wound infected with MRSA is used as the wound healing animal model. The helium atmospheric-pressure dielectric-barrier-discharge (AP-DBD) plasma jet is employed to treat the wounds infected with MRSA. The wound healing, histological, and cytokine analyses are conducted to evaluate the efficacy of the helium AP-DBD plasma jet on the MRSA-infected wound healing process. The experimental results show that the helium AP-DBD plasma jet treatment on the wounds infected with MRSA can regulate the secretion of the cytokines, limit the inflammatory response and cell excessive proliferation, accelerate the process of re-epithelialization, and consequently, promote the wound healing process and the inactivation of the bacteria.
Cold atmospheric plasmas (CAPs) used in plasma medicine have shown great potential in various aspects including wound healing, dermatology, cancer therapy, etc. It is one of the important issues to determine the plasma dosage in plasma medicine because it dominates the specific plasma treatment results. However, the multi-process interactions between CAPs and biological materials make it rather challenging to give an accurate and versatile definition for plasma dosage. In this study, the ratio of the discharge energy to the number of the treated in vitro kidney cells (mJ/cell) was employed as the unit of the plasma dosage. Additionally, inspired by basic knowledge of pharmacy, the median lethal dose (LD50) was employed to help estimate the plasma dosage. The experimental results show that the value of LD50 using the newly designed CAP Bio-Med Platform for the kidney cells is 34.67 mJ/cell. This biology-based method has the advantages of easy operation, independence of specific CAP sources, and also independence of complex interactions between CAPs and the treated biological targets, and consequently, may provide a new direction to quantitatively define the plasma dosage in various plasma medical applications.
Determination of the key chemical reaction pathways in cold atmospheric plasmas (CAPs) is of great importance not only for understanding the spatiotemporal evolutions of the key plasma parameters during discharges but also for improving the plasma materials processing qualities. In this paper, a novel chemical reaction reduction method (CRRM) is proposed by using the global fluid model coupled with the genetic algorithm and the dynamic programming technique. With the aid of this newly developed CRRM, the key chemical reaction pathways can be automatically screened with a high computational efficiency under a pre-set critical calculation accuracy for the atmospheric pure helium and helium–nitrogen glow discharge plasmas. By comparing the calculated key plasma parameters, e.g., the species number densities, electron temperatures, voltage–current characteristics, based on the simplified models and their corresponding full models with those of the experimentally measured data, the reliability of the CRRM itself and the established key chemical reaction database for the atmospheric pure helium and helium–nitrogen CAPs are validated. This research also provides a general method for screening the key chemical reaction pathways for various low-temperature plasma sources.
1 January 2022 in Plasma Sources Science and Technology
During discharges of an arc plasma, complex mass, momentum and energy exchanges exist between the arc column and the surrounding cold gas, forming a nonequilibrium region deviating from both the local thermodynamic equilibrium and local chemical equilibrium states. The nonequilibrium synergistic transport plays a crucial role not only in controlling the characteristics of the arc plasmas theoretically, but also in optimizing the plasma material processing qualities in actual applications. In this paper, the nonequilibrium transport processes in free-burning argon arc plasmas under different operating pressures and arc currents are studied based on a complete nonequilibrium fluid model, and are also validated by comparing with measured data. The energy transfer processes under various operating conditions, especially Joule heating, elastic and inelastic collisions, conductive and convective heat transfer, and energy transfer related to the temperature ratio spatial gradient, are analyzed based on the concept of the ‘energy tree.’ The revealed major energy transfer channels in the high-pressure argon arc plasmas also provide some possibilities to control the characteristics of thermal plasmas in the future.